Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Plain-language summary

This study aims to predict, at a molecular level, the development, progression or complications of kidney disease by collecting biological samples from patients who have or are at risk of kidney disease. It enrolls patients over 18 who are followed in the Nephrology and Organ Transplantation department of Toulouse University Hospital. This is a study without a phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

University Hospital, Toulouse

Intervention

Biological samples collection

Start date

9/5/2022

Estimated completion

9/1/2032

Countries

France

Related genes

Locations

• Toulouse, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients (\> 18 year of age) with kidney disease or at risk to develop a kidney disease,
* Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France)

Exclusion Criteria:

* consent deny
* inability of the patient or its family to give consent.